A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Common cancer screenings aimed at detecting and treating the disease early may not be as effective at extending a person's life expectancy as previously thought. Researchers reviewed clinical trials ...

John Mason, of Rugeley, was referred by a GP to the urology department at Queen’s Hospital in Burton-upon-Trent with a significant increase of the protein prostate-specific antigen (PSA) in his blood ...

A new population-level study from Uppsala University has found that most men treated for non-metastatic prostate cancer according to current clinical guidelines have a favorable long-term prognosis.

Image: Prostate cancer cell. Anne Weston, Francis Crick Institute. A new radioactive medicine that seeks out tumour cells to deliver a targeted dose of radiation greatly improves quality of life for ...

The study focused on patients diagnosed with advanced prostate cancer, where cells have spread to other parts of the body, who were starting their first treatment and who also had alterations in genes ...

Prostate cancer is one of the most common types of cancer across the globe, affecting 1 in 8 men in their lifetimes. A number of famous faces such as BBC and ITV sports broadcaster Steve Rider and ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23 January). NICE has recommended talazoparib ...